Jade Biosciences JBIO
NASDAQ JBIO
$14.18 -0.17 (-1.18%)
At close: Sep 29, 2026 · 4:00 PM EDT

Jade Biosciences (JBIO) Total Current Liabilities (2020 - 2026)

Updated

Jade Biosciences (JBIO) posted Total Current Liabilities of $31.57 million for Q2 2026, up 46.0% from $21.62 million a year earlier and up 41.6% from the prior quarter.

Analysis

Jade Biosciences (JBIO) Total Current Liabilities (2020 - 2026) Analysis & Trends

At the end of FY2025, Jade Biosciences' Total Current Liabilities came in at $16.54 million, up 37.9% from FY2024.

  • Annual Total Current Liabilities shows a five-year compound annual growth rate of 56.3% (FY2020 to FY2025).
  • In prior years, Jade Biosciences' Total Current Liabilities was $12 million in FY2024 (-32.0%), $17.64 million in FY2023 (+126.6%), $7.78 million in FY2022 (+205.2%) and $2.55 million in FY2021 (+43.7%).
  • The Q2 2026 figure stands as the highest quarterly Total Current Liabilities in data going back to Q4 2020.
  • On a year-over-year basis, Total Current Liabilities has increased in each of the last five quarters, with growth averaging 113.0% over the last eight quarters.
  • The strongest year-over-year quarter for Total Current Liabilities in the past five years was Q1 2026, with growth of 822.3%; the weakest was Q1 2025, with a decline of 84.4%.
  • According to Business Quant data, Total Current Liabilities for the three prior quarters was $22.29 million (Q1 2026), $16.54 million (Q4 2025) and $22.36 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 54.90 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 41.64 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 27.73 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 31.75 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -31.55 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 25.50 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 11.02 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 32.65 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 3.94 Bn
10 Jade Biosciences 912.03 Mn 912.03 Mn - 31.57 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 31.57 Mn
Mar 31, 2026 22.29 Mn
Dec 31, 2025 16.54 Mn
Sep 30, 2025 22.36 Mn
Jun 30, 2025 21.62 Mn
Mar 31, 2025 2.42 Mn
Dec 31, 2024 12.00 Mn
Sep 30, 2024 10.32 Mn
Jun 30, 2024 17.02 Mn
Mar 31, 2024 15.52 Mn
Dec 31, 2023 17.64 Mn
Sep 30, 2023 14.73 Mn
Jun 30, 2023 13.28 Mn
Mar 31, 2023 10.64 Mn
Dec 31, 2022 7.78 Mn
Sep 30, 2022 7.71 Mn
Jun 30, 2022 3.76 Mn
Mar 31, 2022 4.70 Mn
Dec 31, 2021 2.55 Mn
Sep 30, 2021 3.83 Mn
API Access

Jade Biosciences Total Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=JBIO&period=max&api_key=YOUR_API_KEY